中国医药集团有限公司（简称“国药集团”）是由国务院国资委直接管理的以生命健康为主业的中央企业。

中国医药集团有限公司（简称“国药集团”）是由国务院国资委直接管理的以生命健康为主业的中央企业。集团规模、效益和综合实力居于全球同行业领先地位，拥有科技研发、工业制造、物流 …

Sinopharm’s bio-pharm sector covers six major areas of human vaccines, blood products, medical aesthetics, animal health, antibody drugs and medical diagnostics, with the capability of …

国药控股股份有限公司; 中国生物技术股份有限公司; 中国医药工业研究总院; 中国国际医药卫生有限公司; 国药医疗健康产业 ...

May 8, 2021 · The COVID-19 vaccine developed by China's Sinopharm has been approved by the World Health Organization (WHO) for "emergency use." This means its safety, efficacy …

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing Postcode: 100191 Tel: 86-10-82287727 Fax: 86-10-62033332

Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. With a primary focus on life & health, the company owns a …

Dec 16, 2024 · The Center for Drug Evaluation, NMPA, has approved clinical trials of the mpox vaccine co-developed by Beijing Institute of Biological Products Co Ltd under Sinopharm. …

中国医疗器械有限公司; 国药控股分销中心有限公司（全采中心） 国药集团医药物流有限公司; 国药集团化学试剂有限公司

地址：北京市海淀区知春路20号 中国医药大厦 邮编：100191 电话：86-10-82287727 传真：86-10-62033332